oxazoles has been researched along with semaglutide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alkhouri, N; Balendran, C; Billin, AN; Buchholtz, K; Damgaard, LH; Hassanein, T; Herring, R; Huss, RS; Kabler, H; Kayali, Z; Kjær, MS; Kohli, A; Loomba, R; Myers, RP; Noureddin, M; Zhu, Y | 1 |
| Katsiki, N; Polyzos, SA | 1 |
1 trial(s) available for oxazoles and semaglutide
| Article | Year |
|---|---|
Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial.
Topics: Azetidines; Double-Blind Method; Fibrosis; Glucagon-Like Peptides; Humans; Isobutyrates; Isonicotinic Acids; Non-alcoholic Fatty Liver Disease; Oxazoles; Pyrimidines; Treatment Outcome | 2022 |
1 other study(ies) available for oxazoles and semaglutide
| Article | Year |
|---|---|
Semaglutide, cilofexor, and firsocostat for nonalcoholic steatohepatitis: a dance that may need more than one dancer.
Topics: Azetidines; Dancing; Glucagon-Like Peptides; Humans; Isobutyrates; Isonicotinic Acids; Liver; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Oxazoles; Pyrimidines | 2022 |